Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-05-21 @ 2:25 PM
Study NCT ID:
NCT00955760
Status:
COMPLETED
Last Update Posted:
2011-02-08
First Post:
2009-08-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane Mesylate
Sponsor:
Merz Pharmaceuticals GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MRZ 92579/TI/1003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Michael Lissy
Old Organization:
AAIPharma Deutschland GmbH & Co. KG